Platelet-derived growth factor-β receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing

Connective tissue remodeling provides mammals with a rapid mechanism to repair wounds after injury. Inappropriate activation of this reparative process leads to scarring and fibrosis. Here, we studied the effects of platelet-derived growth factor receptor-β blockade in vivo using the platelet-derived growth factor receptor (PDGFR)-β inhibitor imatinib mesylate on tissue repair. After 7 days, healing of wounds was delayed with significantly reduced wound closure and concomitant reduction in myofibroblast frequency, expression of fibronectin ED-A, and collagen type I. Using a collagen type I transgenic reporter mouse, we showed that inhibiting PDGFR-β activation restricted the distribution of collagen-synthesizing cells to wound margins and dramatically reduced cell proliferation in vivo. By 14 days, treated wounds were fully closed. Blocking PDGFR-β signaling did not prevent the differentiation of myofibroblasts in vitro but potently inhibited fibroblast proliferation and migration. In addition, PDGFR-β inhibition in vivo was accompanied by abnormal microvascular morphogenesis reminiscent of that observed in PDGFR-β−/− mice with significantly reduced immunostaining of the pericyte marker NG2. Imatinib treatment also inhibited pericyte proliferation and migration in vitro. This study highlights the significance of PDGFR-β signaling for the recruitment, proliferation, and functional activities of fibro-blasts and pericytes during the early phases of wound healing.

[1]  P. Kovanen,et al.  Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts. , 2006, Biochemical and biophysical research communications.

[2]  Z. Werb,et al.  PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival , 2005, Nature Cell Biology.

[3]  Fabian Kiessling,et al.  Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis , 2005, The Journal of experimental medicine.

[4]  T. Sasaoka,et al.  Deletion of the PDGFR-β Gene Affects Key Fibroblast Functions Important for Wound Healing* , 2005, Journal of Biological Chemistry.

[5]  E. Leof,et al.  The FASEB Journal • Research Communication Imatinib mesylate blocks a non-Smad TGF- � pathway and reduces renal fibrogenesis in vivo , 2022 .

[6]  C. Daniels,et al.  Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. , 2004, The Journal of clinical investigation.

[7]  C. Betsholtz,et al.  A specific requirement for PDGF-C in palate formation and PDGFR-α signaling , 2004, Nature Genetics.

[8]  C. Betsholtz.  Insight into the physiological functions of PDGF through genetic studies in mice. , 2004, Cytokine & growth factor reviews.

[9]  D. Abraham,et al.  Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[10]  Philippe Soriano,et al.  Roles of PDGF in animal development , 2003, Development.

[11]  D. Hanahan,et al.  Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. , 2003, The Journal of clinical investigation.

[12]  A Bayat,et al.  Skin scarring , 2003, BMJ : British Medical Journal.

[13]  J. Bonner,et al.  p38 mitogen-activated protein kinase regulates growth factor-induced mitogenesis of rat pulmonary myofibroblasts. , 2002, American journal of respiratory cell and molecular biology.

[14]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[15]  B. Hinz,et al.  Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. , 2001, The American journal of pathology.

[16]  L. Ellis,et al.  Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. , 2001, Cancer research.

[17]  B. Druker,et al.  Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. , 2000, The Journal of pharmacology and experimental therapeutics.

[18]  C. Heldin,et al.  PDGF-C is a new protease-activated ligand for the PDGF α-receptor , 2000, Nature Cell Biology.

[19]  Anita B. Roberts,et al.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.

[20]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[21]  V. Rajkumar,et al.  Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. , 1999, Arthritis and rheumatism.

[22]  J. Crosby,et al.  Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development. , 1999, The American journal of pathology.

[23]  C. Heldin,et al.  Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.

[24]  F. Grinnell,et al.  Differences in the Regulation of Fibroblast Contraction of Floating Versus Stressed Collagen Matrices* , 1999, The Journal of Biological Chemistry.

[25]  A. Geinoz,et al.  The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, The Journal of cell biology.

[26]  Philippe Soriano.  The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. , 1997, Development.

[27]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[28]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[29]  N. Farrokhnia,et al.  Recruitment of type I collagen producing cells from the microvasculature in vitro. , 1996, Experimental cell research.

[30]  K. Niederreither,et al.  A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice , 1996, The Journal of cell biology.

[31]  K. Rubin,et al.  Pericytes as collagen-producing cells in excessive dermal scarring. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[32]  Philippe Soriano,et al.  Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. , 1994, Genes & development.

[33]  B Swolin,et al.  Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. , 1994, Genes & development.

[34]  C. Alpers,et al.  Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. , 1993, The Journal of clinical investigation.

[35]  G. Raghu,et al.  Effects of platelet-derived growth factor isoforms on human lung fibroblast proliferation and procollagen gene expression. , 1993, Experimental lung research.

[36]  C. Heldin,et al.  PDGF alpha‐ and beta‐receptors activate unique and common signal transduction pathways. , 1992, The EMBO journal.

[37]  C. Heldin,et al.  Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. , 1990, The Journal of clinical investigation.

[38]  Thomas A. Mustoe, MD, FACS,et al.  Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms , 1989, The Journal of cell biology.

[39]  G. Laurent,et al.  * Author for correspondence Summary , 2022 .

[40]  C. Heldin,et al.  Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. , 1988, The EMBO journal.

[41]  Thomas A. Mustoe, MD, FACS,et al.  In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins , 1988, The Journal of experimental medicine.

[42]  C. Betsholtz,et al.  A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. , 2004, Nature genetics.

[43]  W. Stallcup,et al.  NG2 proteoglycan expression by pericytes in pathological microvasculature. , 2002, Microvascular research.

[44]  C. Heldin,et al.  PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. , 2001, Nature cell biology.

[45]  H Li,et al.  PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. , 2000, Nature cell biology.